Renaissance Capital’s Guardant Health GH Stock Holding History

Renaissance Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-43,032	Closed	-$5.38M	–	110
2021 Q3	$5.38M	Buy	+43,032	New	+$5.11M	1.08%	26

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Capital's GH Position: Q4 2021 in Review

Renaissance Capital sold out of Guardant Health (GH) in Q4 2021, closing a stake of 43,032 shares — an estimated $5.38M sold.

Renaissance Capital first reported a position in GH in Q3 2021 and held it in 1 quarter. The position peaked at $5.38M in Q3 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

Renaissance Capital reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
Renaissance Capital sold 43,032 Guardant Health shares in Q4 2021, an estimated $5.38M.
Renaissance Capital first reported a position in Guardant Health in Q3 2021 and held it in 1 quarter.
Renaissance Capital's Guardant Health position peaked at $5.38M in Q3 2021.
396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Renaissance Capital's 13F filing for Q4 2021, filed 1 Feb 2022.